[{"Assets_0_Q3_USD":"370469000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.41","EarningsPerShareBasic_3_Q3_USD":"0.74","EarningsPerShareDiluted_1_Q3_USD":"0.4","EarningsPerShareDiluted_3_Q3_USD":"0.73","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"23614000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"4685000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"8489000.0","NetIncomeLoss_1_Q3_USD":"4720000.0","NetIncomeLoss_3_Q3_USD":"8553000.0","OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q3_USD":"48164000.0","RevenuesConverted_3_Q3_USD":"129556000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"182801000.0","Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"11677000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"11666000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"11553000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"11542000.0","filed":"20171102","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"ANI PHARMACEUTICALS INC","period":"20170930","qtrs":"0","uom":"USD"}]